NEW YORK (GenomeWeb) – Natera reported after the close of the market on Wednesday that its third quarter 2017 revenues were up 5 percent compared to revenues in the third quarter of 2016.

For the three months ended Sept. 30, the San Carlos, California-based molecular diagnostics company reported total revenues of $56.7 million, compared to $53.9 million in Q3 2016, and just beating analysts' average estimate for revenues of $56.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.